Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma

Tumor mitotic rate is a known prognostic variable in Stage I melanoma; however, its importance is unclear in Stages II and III.

Source: Surgery - June 18, 2018 Category: Surgery Authors: Jessica L. Evans, Roberto J. Vidri, Dougald C. MacGillivray, Timothy L. Fitzgerald Source Type: research